Updated Clinical and Correlative Results from the Phase I CRB402 Study of the BCMA-Targeted CAR T Cell Therapy bb21217 in Patients with Relapsed and Refractory Multiple Myeloma

被引：58

作者：

Raje, Noopur S. ^{[1
]}

Shah, Nina ^{[2
]}

Jagannath, Sundar ^{[3
]}

Kaufman, Jonathan L. ^{[4
]}

Siegel, David S. ^{[5
]}

Munshi, Nikhil C. ^{[6
]}

Rosenblatt, Jacalyn ^{[7
]}

Lin, Yi ^{[8
]}

Jakubowiak, Andrzej ^{[9
]}

Timm, Alison ^{[10
]}

Yeri, Ashish ^{[10
]}

Martin, Nathan ^{[11
]}

Campbell, Timothy B. ^{[11
]}

Finney, Olivia ^{[10
]}

Truppel-Hartmann, Anna ^{[10
]}

Petrocca, Fabio ^{[10
]}

Berdeja, Jesus G. ^{[12
]}

Alsina, Melissa ^{[13
]}

机构：

[1] Mass Gen Hosp Canc Ctr, Div Hematol & Oncol, Boston, MA USA

[2] Univ Calif San Francisco, San Francisco, CA 94143 USA

[3] Mt Sinai Med Ctr, Dept Med Hematol & Med Oncol, New York, NY 10029 USA

[4] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA

[5] Hackensack Univ, Med Ctr, Hackensack, NJ USA

[6] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA

[7] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[8] Mayo Clin, Rochester, MN USA

[9] Univ Chicago, Chicago, IL 60637 USA

[10] Bluebird Bio, Cambridge, MA USA

[11] Bristol Myers Squibb, Princeton, NJ USA

[12] Sarah Cannon Res Inst, Nashville, TN USA

[13] H Lee Moffitt Canc Ctr & Res Inst, Hematol Malignancies Program, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA

来源：

关键词：

D O I：

10.1182/blood-2021-146518

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

548

引用

页数：5